BioTech Encyclopedia ⌂ Home

Materials researched for biomedical

Filter:
prototype CRISPR gene editing in human patients 2026

First prime editing in patients

Gori and colleagues used prime editing to correct the mutation behind p47phox-deficient chronic granulomatous disease in two patients' own stem cells (PM359); working NADPH oxidase activity appeared in their neutrophils within a month and lasted through follow-up.

Built / tested: PM359

As reported in: Gori, Haddad, Frangoul et al. (2026). Prime Editing for p47 phox -Deficient Chronic Granulomatous Disease. New England Journal of Medicine. doi:10.1056/nejmoa2509807

Read free · preprint / author manuscript

commercial CRISPR gene editing in human patients 2024

Exa-cel phase 3 in sickle cell disease

Frangoul and colleagues reported that 29 of 30 evaluable patients treated with exa-cel were free of severe vaso-occlusive crises for at least 12 consecutive months.

Built / tested: exa-cel (Casgevy)

As reported in: Frangoul, Locatelli, Sharma et al. (2024). Exagamglogene Autotemcel for Severe Sickle Cell Disease. New England Journal of Medicine. doi:10.1056/NEJMoa2309676

Abstract only

commercial CRISPR gene editing in human patients 2024

Exa-cel phase 3 in beta-thalassemia

Locatelli and colleagues reported that 32 of 35 evaluable patients with transfusion-dependent beta-thalassemia (91%) became transfusion independent after exa-cel.

Built / tested: exa-cel (Casgevy)

As reported in: Locatelli, Lang, Wall et al. (2024). Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia. New England Journal of Medicine. doi:10.1056/NEJMoa2309673

Abstract only

prototype CRISPR gene editing in human patients 2024

CRISPR injected into the eye (EDIT-101)

Pierce and colleagues ran a phase 1–2 study injecting EDIT-101 under the retina of 12 adults and 2 children with CEP290-associated inherited retinal degeneration (a form of LCA10), with safety as the primary outcome.

Built / tested: EDIT-101

As reported in: Pierce, Aleman, Jayasundera et al. (2024). Gene Editing for CEP290 -Associated Retinal Degeneration. New England Journal of Medicine. doi:10.1056/NEJMoa2309915

Read free · preprint / author manuscript

lab AI-discovered antibiotics (halicin, abaucin) 2023

Abaucin

Liu and colleagues used a neural network to find abaucin, a narrow-spectrum antibiotic against Acinetobacter baumannii that disrupts lipoprotein trafficking.

As reported in: Liu, Catacutan, Rathod et al. (2023). Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nature Chemical Biology. doi:10.1038/s41589-023-01349-8

Abstract only

prototype Brain-computer interfaces 2023

Speech neuroprosthesis at 62 words per minute

Willett and colleagues decoded attempted speech from intracortical arrays in a person with ALS at 62 words per minute, with a 9.1% word error rate on a 50-word vocabulary and 23.8% on a 125,000-word vocabulary.

As reported in: Willett, Kunz, Fan et al. (2023). A high-performance speech neuroprosthesis. Nature. doi:10.1038/s41586-023-06377-x

Read free · publisher open access

prototype Brain-computer interfaces 2023

Brain to text, voice and talking avatar

Metzger and colleagues decoded brain surface recordings from a woman with severe paralysis into text (median 78 words per minute, 25% word error rate), synthesized speech in her pre-injury voice, and a facial avatar.

Publisher update notice: correction

As reported in: Metzger, Littlejohn, Silva et al. (2023). A high-performance neuroprosthesis for speech decoding and avatar control. Nature. doi:10.1038/s41586-023-06443-4

Read free · preprint / author manuscript

prototype Brain-computer interfaces 2023

Walking again with a brain-spine interface

Lorach and colleagues linked brain implants to spinal cord stimulation so a man with chronic tetraplegia could stand, walk and climb stairs; it stayed reliable for a year, and he could walk with crutches even with it switched off.

As reported in: Lorach, Galvez, Spagnolo et al. (2023). Walking naturally after spinal cord injury using a brain–spine interface. Nature. doi:10.1038/s41586-023-06094-5

Read free · publisher open access

prototype Brain-computer interfaces 2023

BrainGate long-term safety

Rubin and colleagues reported 14 BrainGate participants implanted 2004–2021 with 12,203 days of combined experience; there were 68 device-related adverse events, including 6 serious ones.

Built / tested: BrainGate

As reported in: Rubin, Ajiboye, Barefoot et al. (2023). Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System. Neurology. doi:10.1212/WNL.0000000000201707

Read free · publisher open access

review Collagen & gelatin 2022

Collagen type I biomaterials

A comprehensive review of collagen type I biomaterials for tissue engineering, from biosynthesis to scaffolds.

As reported in: Amirrah, Lokanathan, Zulkiflee et al. (2022). A Comprehensive Review on Collagen Type I Development of Biomaterials for Tissue Engineering: From Biosynthesis to Bioscaffold. Biomedicines. doi:10.3390/biomedicines10092307

Read free · publisher open access

commercial CRISPR gene editing in human patients 2021

First CRISPR patients with sickle cell and beta-thalassemia

Frangoul and colleagues edited the BCL11A enhancer in patients' own blood stem cells; more than a year after infusion, one patient with beta-thalassemia and one with sickle cell disease had raised fetal hemoglobin, no longer needed transfusions, and (in sickle cell) had no pain crises.

Built / tested: exa-cel (Casgevy)

As reported in: Frangoul, Altshuler, Cappellini et al. (2021). CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. New England Journal of Medicine. doi:10.1056/NEJMoa2031054

Read free · publisher open access

prototype CRISPR gene editing in human patients 2021

First CRISPR editing inside the body

Gillmore and colleagues gave six patients with hereditary transthyretin amyloidosis a single infusion of NTLA-2001, which edits the TTR gene in the liver; serum TTR fell by a mean of 52% at the lower dose and 87% at the higher dose by day 28, with mostly mild side effects.

Built / tested: NTLA-2001

As reported in: Gillmore, Gane, Taubel et al. (2021). CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis. New England Journal of Medicine. doi:10.1056/NEJMoa2107454

Read free · publisher open access

lab CRISPR gene editing in human patients 2021

Base editing lowers cholesterol in monkeys

Musunuru and colleagues used lipid nanoparticles to deliver an adenine base editor that switched off PCSK9 in monkey livers; blood PCSK9 fell about 90% and LDL cholesterol about 60%, stable for at least 8 months after one dose.

Built / tested: VERVE-101

As reported in: Musunuru, Chadwick, Mizoguchi et al. (2021). In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature. doi:10.1038/s41586-021-03534-y

Abstract only

prototype Wolbachia and dengue control 2021

Yogyakarta dengue trial

Utarini and colleagues ran a cluster-randomized trial in Yogyakarta, Indonesia; releasing wMel-carrying mosquitoes gave 77.1% protective efficacy against confirmed dengue and 86.2% against dengue hospitalization.

Built / tested: wMel mosquito releases

As reported in: Utarini, Indriani, Ahmad et al. (2021). Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue. New England Journal of Medicine. doi:10.1056/NEJMoa2030243

Read free · publisher open access

lab AI-discovered antibiotics (halicin, abaucin) 2020

Halicin

Stokes and colleagues trained a deep neural network that identified halicin, structurally unlike known antibiotics, which killed a wide range of pathogens and treated C. difficile and pan-resistant A. baumannii infections in mice.

Publisher update notice: erratum

As reported in: Stokes, Yang, Swanson et al. (2020). A Deep Learning Approach to Antibiotic Discovery. Cell. doi:10.1016/j.cell.2020.01.021

Read free · publisher open access

prototype Brain-computer interfaces 2020

Stentrode implanted through a blood vessel

Oxley and colleagues implanted the Synchron Stentrode through a vein into the brain's superior sagittal sinus in two people with ALS, who used it at home with an eye tracker to type and control Windows; one reached 92.63% click accuracy.

Built / tested: Stentrode

As reported in: Oxley, Yoo, Rind et al. (2020). Motor neuroprosthesis implanted with neurointerventional surgery improves capacity for activities of daily living tasks in severe paralysis: first in-human experience. Journal of NeuroInterventional Surgery. doi:10.1136/neurintsurg-2020-016862

Read free · publisher open access

lab Collagen & gelatin 2020

Silk-gelatin microcarriers

Silk fibroin/gelatin microcarriers used as scaffolds for bone tissue engineering.

Built / tested: microcarriers

As reported in: Luetchford, Chaudhuri, De Bank (2020). Silk fibroin/gelatin microcarriers as scaffolds for bone tissue engineering. Materials Science and Engineering: C. doi:10.1016/j.msec.2019.110116

Read free · publisher open access

lab Ultraviolet (UV-C, far-UVC 222 nm, vitamin D) 2020

Far-UVC kills airborne coronaviruses

Buonanno and colleagues found 1.7 and 1.2 mJ/cm² of 222 nm light inactivated 99.9% of airborne coronaviruses 229E and OC43.

Publisher update notice: correction

As reported in: Buonanno, Welch, Shuryak et al. (2020). Far-UVC light (222 nm) efficiently and safely inactivates airborne human coronaviruses. Scientific Reports. doi:10.1038/s41598-020-67211-2

Read free · publisher open access

lab Gravity, microgravity and the body 2019

The NASA Twins Study

Garrett-Bakelman and colleagues compared an astronaut during a year on the ISS with his identical twin on Earth and found changes including telomere lengthening, gene-expression and microbiome changes and some post-flight cognitive decline; most returned near baseline within 6 months.

As reported in: Garrett-Bakelman, Darshi, Green et al. (2019). The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight. Science. doi:10.1126/science.aau8650

Read free · preprint / author manuscript

lab Lignin 2019

Adhesive, tough lignin hydrogel

A plant-inspired adhesive and tough hydrogel built around silver-lignin nanoparticles that drive catechol chemistry.

Built / tested: hydrogels

As reported in: Gan, Xing, Jiang et al. (2019). Plant-inspired adhesive and tough hydrogel based on Ag-Lignin nanoparticles-triggered dynamic redox catechol chemistry. Nature Communications. doi:10.1038/s41467-019-09351-2

Read free · publisher open access

prototype Phage therapy 2019

Engineered phages for resistant infection

Dedrick and colleagues used genetically engineered phages to treat a teenager with a drug-resistant Mycobacterium infection.

Built / tested: engineered phage cocktail

As reported in: Dedrick, Guerrero-Bustamante, Garlena et al. (2019). Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nature Medicine. doi:10.1038/s41591-019-0437-z

Read free · preprint / author manuscript

prototype Phage therapy 2019

PhagoBurn trial

Jault and colleagues ran a clinical trial of a phage cocktail on infected burn wounds; it worked more slowly than standard care.

As reported in: Jault, Leclerc, Jennes et al. (2019). Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. The Lancet Infectious Diseases. doi:10.1016/S1473-3099(18)30482-1

Read free · preprint / author manuscript

review Phage therapy 2019

Phage therapy review

Kortright and colleagues reviewed phage therapy as a renewed approach to antibiotic-resistant bacteria.

As reported in: Kortright, Chan, Koff et al. (2019). Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. Cell Host & Microbe. doi:10.1016/j.chom.2019.01.014

Read free · publisher open access

lab Acoustic cell patterning (standing waves) 2018

Aligned muscle from sound patterning

Armstrong and colleagues used ultrasound standing waves to arrange muscle precursor cells in hydrogels, producing aligned muscle fibres 120–150 µm wide with stronger, direction-dependent tensile properties.

As reported in: Armstrong, Puetzer, Serio et al. (2018). Engineering Anisotropic Muscle Tissue using Acoustic Cell Patterning. Advanced Materials. doi:10.1002/adma.201802649

Read free · publisher open access

lab Alginate (seaweed) 2018

Collagen-alginate bioink

Collagen-alginate used as a bioink for 3D cell printing in cartilage tissue engineering.

Built / tested: bioinks

As reported in: Yang, Lu, Wu et al. (2018). Collagen-alginate as bioink for three-dimensional (3D) cell printing based cartilage tissue engineering. Materials Science and Engineering: C. doi:10.1016/j.msec.2017.09.002

Abstract only

review Hydroxyapatite 2018

Nano-HAp dental implant coatings

A short review of nanohydroxyapatite as a coating for dental implants.

As reported in: Yazdani, Ahmadian, Sharifi et al. (2018). A short view on nanohydroxyapatite as coating of dental implants. Biomedicine & Pharmacotherapy. doi:10.1016/j.biopha.2018.06.013

Abstract only

lab Ultraviolet (UV-C, far-UVC 222 nm, vitamin D) 2018

Far-UVC kills airborne flu

Welch and colleagues showed 2 mJ/cm² of 222 nm far-UVC inactivated over 95% of airborne H1N1 influenza virus; it cannot penetrate the outer dead layers of skin or eye.

Publisher update notice: correction

As reported in: Welch, Buonanno, Grilj et al. (2018). Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases. Scientific Reports. doi:10.1038/s41598-018-21058-w

Read free · publisher open access

review Aluminum 2018

Aluminium vaccine adjuvants

HogenEsch, O'Hagan and Fox reviewed aluminium-containing adjuvants, used for over 90 years to strengthen immune responses to vaccines, and argued they should stay the benchmark for comparing new adjuvants.

As reported in: HogenEsch, O’Hagan, Fox (2018). Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want. npj Vaccines. doi:10.1038/s41541-018-0089-x

Read free · publisher open access

commercial AAV gene delivery 2017

Voretigene (Luxturna) phase 3 trial

Russell and colleagues reported the phase 3 trial of an AAV gene therapy for RPE65 blindness, later approved as Luxturna.

Built / tested: Luxturna

As reported in: Russell, Bennett, Wellman et al. (2017). Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. The Lancet. doi:10.1016/S0140-6736(17)31868-8

Read free · preprint / author manuscript

commercial AAV gene delivery 2017

Gene therapy for spinal muscular atrophy

Mendell and colleagues gave infants with SMA a single AAV gene-replacement dose, greatly improving survival.

Built / tested: onasemnogene (Zolgensma)

As reported in: Mendell, Al-Zaidy, Shell et al. (2017). Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. New England Journal of Medicine. doi:10.1056/NEJMoa1706198

Read free · publisher open access

prototype Induced pluripotent stem cells (iPSCs) 2017

First iPSC-derived retinal transplant

Mandai and colleagues reported transplanting a sheet of retinal cells grown from a patient's own iPS cells in a patient with macular degeneration; after a year the sheet was intact and vision had neither improved nor worsened.

Built / tested: retinal pigment epithelium sheet

As reported in: Mandai, Watanabe, Kurimoto et al. (2017). Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration. New England Journal of Medicine. doi:10.1056/NEJMoa1608368

Read free · publisher open access

lab Keratin 2017

Feather keratin wound hydrogel

Prepared a feather keratin hydrogel and evaluated its wound-healing effect and biocompatibility.

Publisher update notice: erratum

Built / tested: hydrogels

As reported in: Wang, Hao, Luo et al. (2017). Feather keratin hydrogel for wound repair: Preparation, healing effect and biocompatibility evaluation. Colloids and Surfaces B: Biointerfaces. doi:10.1016/j.colsurfb.2016.10.038

Abstract only

prototype Lab-grown & artificial skin 2017

Whole epidermis from gene-corrected stem cells

Hirsch and colleagues regrew most of a boy's skin using genetically corrected stem cells for the blistering disease epidermolysis bullosa.

Built / tested: transgenic epidermis grafts

As reported in: Hirsch, Rothoeft, Teig et al. (2017). Regeneration of the entire human epidermis using transgenic stem cells. Nature. doi:10.1038/nature24487

Read free · preprint / author manuscript

prototype Phage therapy 2017

Personalized phage cocktail saves a patient

Schooley and colleagues treated a patient with a resistant Acinetobacter infection using custom phage cocktails.

Publisher update notice: correction

As reported in: Schooley, Biswas, Gill et al. (2017). Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.00954-17

Read free · publisher open access

lab Gravity, microgravity and the body 2016

Human cells in microgravity

Mukhopadhyay and colleagues reanalysed published gene-expression data from human cells in microgravity and identified about 100 shared pathways, many linked to reduced inflammation and immunity.

As reported in: Mukhopadhyay, Saha, Palanisamy et al. (2016). A systems biology pipeline identifies new immune and disease related molecular signatures and networks in human cells during microgravity exposure. Scientific Reports. doi:10.1038/srep25975

Read free · publisher open access

review Proton and particle beam therapy 2016

Nuclear physics in particle therapy

Durante and Paganetti reviewed particle therapy: ions deposit more energy along their path, sparing normal tissue compared with photons, but it remains controversial due to high cost and lack of comparative trials.

As reported in: Durante, Paganetti (2016). Nuclear physics in particle therapy: a review. Reports on Progress in Physics. doi:10.1088/0034-4885/79/9/096702

Read free · publisher open access

commercial Ultrasound (imaging, focused ultrasound, sonogenetics) 2016

Focused ultrasound for tremor

Elias and colleagues ran a randomized trial in 76 patients: MRI-guided focused ultrasound thalamotomy cut hand-tremor scores from 18.1 to 9.6 at 3 months, versus almost no change with sham, and the benefit held at 12 months.

As reported in: Elias, Lipsman, Ondo et al. (2016). A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor. New England Journal of Medicine. doi:10.1056/NEJMoa1600159

Read free · publisher open access

review Zirconium 2016

Titanium vs zirconia dental implants

Bosshardt, Chappuis and Buser reviewed how bone heals onto titanium, titanium-zirconium and zirconia dental implants; micro-rough surfaces speed bone bonding (osseointegration) on titanium, and surface changes also affect how fast zirconia implants integrate.

As reported in: Bosshardt, Chappuis, Buser (2016). Osseointegration of titanium, titanium alloy and zirconia dental implants: current knowledge and open questions. Periodontology 2000. doi:10.1111/prd.12179

Abstract only

lab Ultrasound (imaging, focused ultrasound, sonogenetics) 2015

Super-resolution ultrasound of blood vessels

Errico and colleagues used ultrafast ultrasound to track gas microbubbles in blood, producing super-resolution images of microvessels deep in the body, analogous to optical localization microscopy.

As reported in: Errico, Pierre, Pezet et al. (2015). Ultrafast ultrasound localization microscopy for deep super-resolution vascular imaging. Nature. doi:10.1038/nature16066

Abstract only

review Biodegradable metals (zinc and iron) 2014

Biodegradable metals overview

Zheng, Gu, and Witte reviewed magnesium, iron, and zinc as metals designed to degrade safely in the body.

As reported in: Zheng, Gu, Witte (2014). Biodegradable metals. Materials Science and Engineering: R: Reports. doi:10.1016/j.mser.2014.01.001

Abstract only

lab Piezoelectric and triboelectric energy harvesting 2014

Power from heart and lung motion

Dagdeviren and colleagues built flexible piezoelectric harvesters sewn onto the heart, lung and diaphragm of animals, converting organ motion to electricity at about 2% efficiency.

Publisher update notice: correction

As reported in: Dagdeviren, Yang, Su et al. (2014). Conformal piezoelectric energy harvesting and storage from motions of the heart, lung, and diaphragm. Proceedings of the National Academy of Sciences. doi:10.1073/pnas.1317233111

Read free · preprint / author manuscript

lab Biodegradable metals (zinc and iron) 2013

Zinc for bioabsorbable stents

Bowen and colleagues found zinc wires implanted in rat arteries corroded at a rate well suited to dissolving stents.

Built / tested: bioabsorbable stents

As reported in: Bowen, Drelich, Goldman (2013). Zinc Exhibits Ideal Physiological Corrosion Behavior for Bioabsorbable Stents. Advanced Materials. doi:10.1002/adma.201300226

Abstract only

prototype Copper (antimicrobial surfaces) 2013

Copper surfaces in intensive care

Salgado and colleagues found copper surfaces in ICU rooms lowered hospital-acquired infection rates in a clinical trial.

Built / tested: copper hospital surfaces

As reported in: Salgado, Sepkowitz, John et al. (2013). Copper Surfaces Reduce the Rate of Healthcare-Acquired Infections in the Intensive Care Unit. Infection Control & Hospital Epidemiology. doi:10.1086/670207

Abstract only

lab Keratin 2013

Keratin nanoparticles in bone scaffolds

Chitosan scaffolds containing chicken feather keratin nanoparticles for bone tissue engineering.

Built / tested: scaffolds

As reported in: Saravanan, Sameera, Moorthi et al. (2013). Chitosan scaffolds containing chicken feather keratin nanoparticles for bone tissue engineering. International Journal of Biological Macromolecules. doi:10.1016/j.ijbiomac.2013.09.034

Abstract only

review Liposomes and lipid nanoparticles 2013

Liposomal drugs

Allen and Cullis reviewed liposomal drug delivery from concept to clinic.

Built / tested: liposomal drugs

As reported in: Allen, Cullis (2013). Liposomal drug delivery systems: From concept to clinical applications. Advanced Drug Delivery Reviews. doi:10.1016/j.addr.2012.09.037

Abstract only

commercial Arsenic 2013

Retinoic acid plus arsenic trioxide

In a phase 3 trial in low-to-intermediate-risk acute promyelocytic leukemia, all-trans retinoic acid plus arsenic trioxide gave 97% two-year event-free survival versus 86% with retinoic acid plus chemotherapy, with less blood toxicity but more liver toxicity.

As reported in: Lo-Coco, Avvisati, Vignetti et al. (2013). Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia. New England Journal of Medicine. doi:10.1056/nejmoa1300874

Read free · preprint / author manuscript

prototype Brain-computer interfaces 2012

Mind-controlled robotic arm

Hochberg and colleagues showed people with tetraplegia reaching and grasping with a robotic arm controlled by brain signals.

As reported in: Hochberg, Bacher, Jarosiewicz et al. (2012). Reach and grasp by people with tetraplegia using a neurally controlled robotic arm. Nature. doi:10.1038/nature11076

Read free · publisher open access

lab Diatomite 2012

Diatom microshells for drug delivery

Porous silica microshells from diatoms as a biocarrier for drug delivery.

Built / tested: microcarriers

As reported in: Aw, Simovic, Yu et al. (2012). Porous silica microshells from diatoms as biocarrier for drug delivery applications. Powder Technology. doi:10.1016/j.powtec.2011.04.023

Abstract only

prototype DNA nanorobots and walkers 2012

Logic-gated DNA nanorobot

Douglas, Bachelet and Church built a DNA nanorobot that opens to deliver molecular payloads only when aptamer logic gates sense the right cell-surface cues.

As reported in: Douglas, Bachelet, Church (2012). A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads. Science. doi:10.1126/science.1214081

Abstract only

lab Oxygen (hyperbaric and oxygen-releasing materials) 2012

Oxygen-generating materials for islets

Pedraza and colleagues used an oxygen-generating material to protect insulin-producing cells from low oxygen.

As reported in: Pedraza, Coronel, Fraker et al. (2012). Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials. Proceedings of the National Academy of Sciences. doi:10.1073/pnas.1113560109

Read free · publisher open access

review Silica 2012

Mesoporous silica nanoparticles

Synthesis, biocompatibility and drug delivery of mesoporous silica nanoparticles.

As reported in: Tang, Li, Chen (2012). Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery. Advanced Materials. doi:10.1002/adma.201104763

Abstract only

lab Human echolocation 2011

Echoes processed in "visual" brain

Thaler, Arnott and Goodale found that in two blind echolocation experts, listening to click-echoes activated visual (calcarine) cortex, with no echo-related difference in auditory cortex.

As reported in: Thaler, Arnott, Goodale (2011). Neural Correlates of Natural Human Echolocation in Early and Late Blind Echolocation Experts. PLoS ONE. doi:10.1371/journal.pone.0020162

Read free · publisher open access

review Photodynamic therapy 2011

PDT update

Agostinis and colleagues reviewed PDT: a light-activated photosensitizer kills tumour cells, damages tumour vessels and triggers inflammation, and can be curative in early tumours.

As reported in: Agostinis, Berg, Cengel et al. (2011). Photodynamic therapy of cancer: An update. CA: A Cancer Journal for Clinicians. doi:10.3322/caac.20114

Read free · publisher open access

lab Wolbachia and dengue control 2011

wMel blocks dengue in mosquitoes

Walker and colleagues introduced the wMel Wolbachia strain into Aedes aegypti mosquitoes; it blocked dengue, caused the reproductive effect cytoplasmic incompatibility with minimal apparent cost, and spread through caged populations.

As reported in: Walker, Johnson, Moreira et al. (2011). The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature. doi:10.1038/nature10355

Abstract only

commercial Bismuth 2011

Bismuth quadruple therapy for H. pylori

In a phase 3 trial at 39 European sites, 10-day quadruple therapy (omeprazole plus one capsule of bismuth subcitrate potassium, metronidazole and tetracycline) gave superior H. pylori eradication to 7-day clarithromycin-based triple therapy, with similar safety.

Publisher update notice: erratum

As reported in: Malfertheiner, Bazzoli, Delchier et al. (2011). Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. The Lancet. doi:10.1016/s0140-6736(11)60020-2

Abstract only

lab Collagen & gelatin 2010

Pore size in collagen scaffolds

Measured how mean pore size affects cell attachment, growth and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering.

Built / tested: scaffolds

As reported in: Murphy, Haugh, O'Brien (2010). The effect of mean pore size on cell attachment, proliferation and migration in collagen–glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials. doi:10.1016/j.biomaterials.2009.09.063

Abstract only

commercial Gamma rays (sterilization, radiotherapy, Gamma Knife, PET) 2010

Gamma Knife for facial nerve pain

Kondziolka and colleagues reviewed 503 trigeminal neuralgia patients treated with Gamma Knife radiosurgery; 89% achieved adequate or better initial pain relief.

As reported in: Kondziolka, Zorro, Lobato-Polo et al. (2010). Gamma Knife stereotactic radiosurgery for idiopathic trigeminal neuralgia. Journal of Neurosurgery. doi:10.3171/2009.7.jns09694

Abstract only

commercial Industrial enzymes 2010

Engineered enzyme for a diabetes drug

Savile and colleagues evolved a transaminase enzyme to make the drug sitagliptin, replacing a metal-catalysed step in manufacturing.

Built / tested: pharmaceutical manufacturing process

As reported in: Savile, Janey, Mundorff et al. (2010). Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture. Science. doi:10.1126/science.1188934

Abstract only

review Keratin 2010

Keratin biomaterials review

A review of keratin-based biomaterials for biomedical applications.

As reported in: Rouse, Van Dyke (2010). A Review of Keratin-Based Biomaterials for Biomedical Applications. Materials. doi:10.3390/ma3020999

Read free · publisher open access

review Silver (antimicrobial) 2009

Silver as a new antimicrobial

Rai and colleagues reviewed silver nanoparticles as a new generation of antimicrobials.

Built / tested: antimicrobial coatings

As reported in: Rai, Yadav, Gade (2009). Silver nanoparticles as a new generation of antimicrobials. Biotechnology Advances. doi:10.1016/j.biotechadv.2008.09.002

Abstract only

review Titanium and titanium alloys 2009

Titanium for orthopedic implants

Geetha and colleagues reviewed why titanium-based alloys are a leading choice for hip, knee, and other orthopedic implants.

Built / tested: orthopedic implants

As reported in: Geetha, Singh, Asokamani et al. (2009). Ti based biomaterials, the ultimate choice for orthopaedic implants – A review. Progress in Materials Science. doi:10.1016/j.pmatsci.2008.06.004

Abstract only

prototype AAV gene delivery 2008

Gene therapy for inherited blindness

Maguire and colleagues delivered a working RPE65 gene by AAV to three patients with Leber congenital amaurosis; it appeared safe and gave modest improvements in retinal function.

As reported in: Maguire, Simonelli, Pierce et al. (2008). Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis. New England Journal of Medicine. doi:10.1056/NEJMoa0802315

Read free · publisher open access

review Cold gas plasma (plasma medicine) 2008

Applied plasma medicine

Fridman and colleagues reviewed medical uses of plasma.

As reported in: Fridman, Friedman, Gutsol et al. (2008). Applied Plasma Medicine. Plasma Processes and Polymers. doi:10.1002/ppap.200700154

Abstract only

lab Magnetite 2008

Magnetite-silica imaging particles

Uniform nanoparticles with a magnetite core and mesoporous silica shell for MRI and fluorescence imaging and drug delivery.

Built / tested: nanoparticles

As reported in: Kim, Kim, Lee et al. (2008). Multifunctional Uniform Nanoparticles Composed of a Magnetite Nanocrystal Core and a Mesoporous Silica Shell for Magnetic Resonance and Fluorescence Imaging and for Drug Delivery. Angewandte Chemie International Edition. doi:10.1002/anie.200802469

Read free · publisher open access

commercial Visible light (photosynthesis, LEDs, phototherapy) 2008

Light therapy for newborn jaundice

Maisels and McDonagh reviewed phototherapy for neonatal jaundice, used according to guidelines based on bilirubin level, gestational age and risk factors.

As reported in: Maisels, McDonagh (2008). Phototherapy for Neonatal Jaundice. New England Journal of Medicine. doi:10.1056/NEJMct0708376

Abstract only

review Fluorine 2008

Fluorine in medicines

Purser and colleagues reviewed well-known fluorinated drugs, how they work, and how swapping in fluorine affects drug potency.

As reported in: Purser, Moore, Swallow et al. (2008). Fluorine in medicinal chemistry. Chem. Soc. Rev.. doi:10.1039/b610213c

Abstract only

lab Hydrogen gas 2007

Hydrogen as an antioxidant

Ohsawa and colleagues found inhaled hydrogen selectively reduced harmful oxygen radicals in rats.

As reported in: Ohsawa, Ishikawa, Takahashi et al. (2007). Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. doi:10.1038/nm1577

Abstract only

review Nanoparticle drug delivery 2007

Nanocarriers for cancer

Peer and colleagues reviewed nanocarriers and molecules for selective tumour targeting and the challenges in cancer treatment.

As reported in: Peer, Karp, Hong et al. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology. doi:10.1038/nnano.2007.387

Abstract only

prototype Brain-computer interfaces 2006

Person with tetraplegia controls a cursor

Hochberg and colleagues reported a man with paralysis controlling a computer cursor and devices with an implanted array.

Built / tested: BrainGate

As reported in: Hochberg, Serruya, Friehs et al. (2006). Neuronal ensemble control of prosthetic devices by a human with tetraplegia. Nature. doi:10.1038/nature04970

Abstract only

review Magnesium (biodegradable implants) 2006

Magnesium as an orthopedic biomaterial

Staiger and colleagues reviewed magnesium alloys as degradable orthopedic implant materials.

As reported in: Staiger, Pietak, Huadmai et al. (2006). Magnesium and its alloys as orthopedic biomaterials: A review. Biomaterials. doi:10.1016/j.biomaterials.2005.10.003

Abstract only

commercial Medicines from animal venoms 2006

Ziconotide trial in severe chronic pain

Rauck and colleagues found that slowly increasing doses of ziconotide, a non-opioid painkiller delivered into the spinal fluid, significantly improved severe chronic pain and was better tolerated than in earlier trials.

Built / tested: ziconotide

As reported in: Rauck, Wallace, Leong et al. (2006). A Randomized, Double-Blind, Placebo-Controlled Study of Intrathecal Ziconotide in Adults with Severe Chronic Pain. Journal of Pain and Symptom Management. doi:10.1016/j.jpainsymman.2005.10.003

Read free · publisher open access

lab Alginate (seaweed) 2005

In-situ forming wound dressing

Evaluated an in-situ forming hydrogel wound dressing based on oxidised alginate and gelatin.

Built / tested: wound dressings

As reported in: Balakrishnan, Mohanty, Umashankar et al. (2005). Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials. doi:10.1016/j.biomaterials.2005.04.012

Abstract only

review Bone grafts & bone substitutes 2005

Bone substitutes overview

Giannoudis and colleagues reviewed grafts and synthetic bone substitutes used in orthopaedic surgery.

As reported in: Giannoudis, Dinopoulos, Tsiridis (2005). Bone substitutes: An update. Injury. doi:10.1016/j.injury.2005.07.029

Abstract only

lab Magnesium (biodegradable implants) 2005

Magnesium implants dissolving in bone

Witte and colleagues tracked four magnesium alloys corroding inside animal bone and found new bone forming around them.

Built / tested: degradable bone implants

As reported in: Witte, Kaese, Haferkamp et al. (2005). In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials. doi:10.1016/j.biomaterials.2004.09.049

Abstract only

review Boron 2005

Boron neutron capture therapy

Barth, Coderre and colleagues reviewed boron neutron capture therapy, in which boron-10 is hit by low-energy neutrons and gives off high-energy-transfer alpha particles and lithium-7 nuclei; sodium borocaptate and boronophenylalanine are the two boron drugs used in patients.

As reported in: Barth, Coderre, Vicente et al. (2005). Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects. Clinical Cancer Research. doi:10.1158/1078-0432.ccr-05-0035

Read free · publisher open access

lab Thulium 2005

Thulium laser breaks urinary stones

Fried showed a high-power thulium fiber laser at 1.94 µm, run in pulsed mode, could fragment both soft uric acid and hard calcium oxalate monohydrate urinary stones in lab tests.

As reported in: Fried (2005). Thulium fiber laser lithotripsy: An in vitro analysis of stone fragmentation using a modulated 110-watt Thulium fiber laser at 1.94 µm. Lasers in Surgery and Medicine. doi:10.1002/lsm.20196

Abstract only

lab Gravity, microgravity and the body 2004

Bone loss on the space station

Lang and colleagues scanned 14 crew members after 4–6 month ISS flights and found hip bone lost mainly by thinning from the inside; earlier Mir studies had reported losses of about 1% a month from the spine and 1.5% from the hip.

As reported in: Lang, LeBlanc, Evans et al. (2004). Cortical and Trabecular Bone Mineral Loss From the Spine and Hip in Long-Duration Spaceflight. Journal of Bone and Mineral Research. doi:10.1359/jbmr.040307

Read free · publisher open access

lab Human microbiome and the gut-brain axis 2004

Gut microbes shape stress response in mice

Sudo and colleagues found germ-free mice had an exaggerated stress hormone response compared with mice with normal microbes, which was reversed by giving them Bifidobacterium infantis; normal gut microbes only partly corrected it when given early in life, not later.

As reported in: Sudo, Chida, Aiba et al. (2004). Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice. The Journal of Physiology. doi:10.1113/jphysiol.2004.063388

Abstract only

lab Hydroxyapatite 2004

Nano-HAp polymer scaffolds

Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering.

Built / tested: bone scaffolds

As reported in: Wei, Ma (2004). Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials. doi:10.1016/j.biomaterials.2003.12.005

Abstract only

prototype Ruthenium 2004

First human trial of NAMI-A

In a phase I study in 24 patients with solid tumours, the ruthenium compound NAMI-A, which had shown antimetastatic activity in preclinical studies, caused painful blisters at high doses; 300 mg/m2/day was advised for further testing.

Built / tested: NAMI-A

As reported in: Rademaker-Lakhai, van den Bongard, Pluim et al. (2004). A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent. Clinical Cancer Research. doi:10.1158/1078-0432.ccr-03-0746

Read free · preprint / author manuscript

commercial Strontium 2004

Strontium ranelate and vertebral fractures

In a three-year trial in 1,649 postmenopausal women with osteoporosis, oral strontium ranelate reduced the risk of new vertebral fractures by 41% and raised lumbar-spine bone density by 14.4%.

As reported in: Meunier, Roux, Seeman et al. (2004). The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis. New England Journal of Medicine. doi:10.1056/nejmoa022436

Read free · publisher open access

lab Gold nanoparticles 2003

Gold nanoshell tumor heating

Hirsch and colleagues used gold nanoshells and near-infrared light to heat and destroy tumors in mice.

As reported in: Hirsch, Stafford, Bankson et al. (2003). Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proceedings of the National Academy of Sciences. doi:10.1073/pnas.2232479100

Read free · publisher open access

review Hydrogels 2003

Hydrogels for tissue engineering

Drury and Mooney reviewed hydrogel scaffolds for tissue engineering.

As reported in: Drury, Mooney (2003). Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. doi:10.1016/S0142-9612(03)00340-5

Abstract only

review Photodynamic therapy 2003

Photodynamic therapy for cancer

Dolmans, Fukumura and Jain reviewed photodynamic therapy for cancer.

As reported in: Dolmans, Fukumura, Jain (2003). Photodynamic therapy for cancer. Nature Reviews Cancer. doi:10.1038/nrc1071

Abstract only

commercial Lanthanum 2003

Lanthanum carbonate phosphate binder

In a phase III placebo-controlled study in hemodialysis patients, lanthanum carbonate, a phosphate binder without calcium or aluminium, lowered serum phosphorus and was well tolerated.

As reported in: Joy, Finn (2003). Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia. American Journal of Kidney Diseases. doi:10.1016/s0272-6386(03)00554-7

Abstract only

review Parasites that change host behaviour 2002

Rabies and the brain

Hemachudha, Laothamatas and Rupprecht reviewed human rabies as a disease of complex effects on the nervous system that is difficult to diagnose.

As reported in: Hemachudha, Laothamatas, Rupprecht (2002). Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. The Lancet Neurology. doi:10.1016/S1474-4422(02)00041-8

Abstract only

commercial Magnesium 2002

Magnesium sulphate prevents eclampsia

In the Magpie Trial of 10,141 women with pre-eclampsia in 33 countries, those given magnesium sulphate had a 58% lower risk of eclampsia than those given placebo.

As reported in: (2002). Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. The Lancet. doi:10.1016/s0140-6736(02)08778-0

Abstract only

lab Alginate (seaweed) 2001

Alginate gel scaffolds

Studied structure, gelation rate and mechanical properties of ionically crosslinked alginate hydrogels as tissue engineering scaffolds.

Built / tested: hydrogel scaffolds

As reported in: Kuo, Ma (2001). Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: Part 1. Structure, gelation rate and mechanical properties. Biomaterials. doi:10.1016/s0142-9612(00)00201-5

Abstract only

lab Ultrasound (imaging, focused ultrasound, sonogenetics) 2001

Opening the blood-brain barrier

Hynynen and colleagues used focused ultrasound plus a contrast agent to open the blood-brain barrier locally in rabbits, without damaging surrounding neurons at the lowest powers.

As reported in: Hynynen, McDannold, Vykhodtseva et al. (2001). Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits. Radiology. doi:10.1148/radiol.2202001804

Abstract only

lab Gravity, microgravity and the body 2000

Cosmonaut bone loss

Vico and colleagues studied the effects of long-term microgravity on weight-bearing bones of cosmonauts.

As reported in: Vico, Collet, Guignandon et al. (2000). Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. The Lancet. doi:10.1016/S0140-6736(00)02217-0

Abstract only

lab Hydrogen sulfide and carbon monoxide (signaling gases) 2000

Carbon monoxide reduces inflammation

Otterbein and colleagues found low-dose carbon monoxide had anti-inflammatory effects.

As reported in: Otterbein, Bach, Alam et al. (2000). Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Medicine. doi:10.1038/74680

Abstract only

lab Magnetite 1999

Magnetic fluid hyperthermia

Described magnetic fluid hyperthermia, heating superparamagnetic nanoparticles with an AC magnetic field to treat cancer.

As reported in: Jordan, Scholz, Wust et al. (1999). Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. Journal of Magnetism and Magnetic Materials. doi:10.1016/s0304-8853(99)00088-8

Abstract only

commercial Nitinol (shape-memory alloy) 1999

Nitinol medical devices

Duerig, Pelton, and Stöckel reviewed nitinol in stents, guidewires, and other medical devices.

Built / tested: stents, guidewires

As reported in: Duerig, Pelton, Stöckel (1999). An overview of nitinol medical applications. Materials Science and Engineering: A. doi:10.1016/S0921-5093(99)00294-4

Abstract only

lab Tantalum 1999

Bone grows into porous tantalum

Bobyn and colleagues implanted a 75–80% porous tantalum material in dogs; new bone filled 42–53% of the pores by four weeks and 63–80% by 16 to 52 weeks, with a shear fixation strength of at least 18.5 MPa at four weeks.

As reported in: Bobyn, Stackpool, Hacking et al. (1999). Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. The Journal of Bone and Joint Surgery. British volume. doi:10.1302/0301-620x.81b5.0810907

Abstract only

review Medicines from animal venoms 1998

Cone snail toxin as a painkiller

Bowersox and Luther reviewed the therapeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type calcium channel blocker from the venom of the cone snail Conus magus.

Built / tested: ziconotide

As reported in: Bowersox, Luther (1998). Pharmacotherapeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type neuronal calcium channel blocker found in the venom of Conus magus. Toxicon. doi:10.1016/s0041-0101(98)00158-5

Abstract only

review Titanium and titanium alloys 1998

Mechanical properties of titanium alloys

Niinomi compared the strength, fatigue, and stiffness of biomedical titanium alloys.

As reported in: Niinomi (1998). Mechanical properties of biomedical titanium alloys. Materials Science and Engineering: A. doi:10.1016/S0921-5093(97)00806-X

Abstract only

lab Xenon and helium (noble gases in medicine) 1998

How xenon causes anesthesia

Franks and colleagues showed xenon blocks NMDA receptors, explaining its anesthetic effect.

As reported in: Franks, Dickinson, de Sousa et al. (1998). How does xenon produce anaesthesia?. Nature. doi:10.1038/24525

Abstract only

commercial Erbium 1998

Er:YAG laser for tooth decay

In a study of 103 patients at five dental hospitals, Er:YAG laser cavity preparation was more comfortable than conventional mechanical drilling, and 82% of patients said they would prefer the laser for future caries treatment.

As reported in: Keller, Hibst, Geurtsen et al. (1998). Erbium:YAG laser application in caries therapy. Evaluation of patient perception and acceptance. Journal of Dentistry. doi:10.1016/s0300-5712(97)00036-5

Abstract only

lab Animal cloning (Dolly the sheep) 1997

Polly: cloned transgenic sheep

Schnieke and colleagues produced cloned sheep carrying a human clotting factor IX gene.

Built / tested: transgenic cloned sheep

As reported in: Schnieke, Kind, Ritchie et al. (1997). Human Factor IX Transgenic Sheep Produced by Transfer of Nuclei from Transfected Fetal Fibroblasts. Science. doi:10.1126/science.278.5346.2130

Abstract only

commercial Brain-computer interfaces 1997

The Utah electrode array

Maynard, Nordhausen and Normann described the Utah intracortical array as a recording structure for brain-computer interfaces.

Built / tested: Utah array

As reported in: Maynard, Nordhausen, Normann (1997). The Utah Intracortical Electrode Array: A recording structure for potential brain-computer interfaces. Electroencephalography and Clinical Neurophysiology. doi:10.1016/S0013-4694(96)95176-0

Abstract only

review Starch & PLA bioplastics 1997

PLA and PLGA microspheres

A review of the biodegradation and biocompatibility of PLA and PLGA microspheres.

As reported in: Anderson, Shive (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews. doi:10.1016/s0169-409x(97)00048-3

Abstract only

prototype Arsenic 1997

Arsenic trioxide for relapsed APL

Shen and colleagues gave arsenic trioxide to 15 patients with relapsed acute promyelocytic leukemia; 9 of 10 treated with it alone reached complete remission, without bone-marrow suppression.

As reported in: Shen, Chen, Ni et al. (1997). Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients. Blood. doi:10.1182/blood.v89.9.3354

Abstract only

lab Cold gas plasma (plasma medicine) 1996

Plasma sterilization

Laroussi showed an atmospheric-pressure plasma can sterilize contaminated material.

As reported in: Laroussi (1996). Sterilization of contaminated matter with an atmospheric pressure plasma. IEEE Transactions on Plasma Science. doi:10.1109/27.533129

Abstract only

commercial Cartilage repair 1994

Autologous chondrocyte implantation

Brittberg and colleagues treated deep knee cartilage defects by growing the patient's own cartilage cells and implanting them.

Built / tested: ACI procedure

As reported in: Brittberg, Lindahl, Nilsson et al. (1994). Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte Transplantation. New England Journal of Medicine. doi:10.1056/NEJM199410063311401

Read free · publisher open access

lab Xenon and helium (noble gases in medicine) 1994

Hyperpolarized xenon MRI

Albert and colleagues produced the first biological MRI images using laser-polarized xenon-129.

As reported in: Albert, Cates, Driehuys et al. (1994). Biological magnetic resonance imaging using laser-polarized 129Xe. Nature. doi:10.1038/370199a0

Abstract only

commercial Medicines from animal venoms 1992

Exendin-4 from Gila monster venom

Eng and colleagues isolated exendin-4, a 39-amino-acid peptide, from the venom of the Gila monster (Heloderma suspectum).

Built / tested: exenatide

As reported in: Eng, Kleinman, Singh et al. (1992). Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.. Journal of Biological Chemistry. doi:10.1016/s0021-9258(18)42531-8

Read free · publisher open access

review Gamma rays (sterilization, radiotherapy, Gamma Knife, PET) 1990

Radiation sterilization of medical devices

A 1990 review covered the state of the art in radiation sterilization of medical devices.

As reported in: Dorpema (1990). Review and state of the art on radiation sterilization of medical devices. International Journal of Radiation Applications and Instrumentation. Part C. Radiation Physics and Chemistry. doi:10.1016/1359-0197(90)90118-2

Abstract only

lab Fractals in biology and allometric scaling laws 1988

Fractal model of lung growth

Nelson and Manchester modelled lung airway growth with fractal concepts, producing structures in good agreement with measured airway data.

As reported in: Nelson, Manchester (1988). Modeling of lung morphogenesis using fractal geometries. IEEE Transactions on Medical Imaging. doi:10.1109/42.14515

Abstract only

lab Coral (coralline bone substitutes) 1987

Coral as a bone graft substitute

Guillemin and colleagues studied natural coral as a bone graft substitute.

As reported in: Guillemin, Patat, Fournie et al. (1987). The use of coral as a bone graft substitute. Journal of Biomedical Materials Research. doi:10.1002/jbm.820210503

Abstract only

lab Prions 1982

Proteinaceous infectious particles cause scrapie

Prusiner presented six lines of evidence that the scrapie agent needs a protein to be infectious and resists procedures that modify nucleic acids, and proposed the term prion for this new kind of agent.

As reported in: Prusiner (1982). Novel Proteinaceous Infectious Particles Cause Scrapie. Science. doi:10.1126/science.6801762

Abstract only

commercial Coral (coralline bone substitutes) 1979

Coralline hydroxyapatite implant

Holmes reported bone regrowing in dogs within coral-derived hydroxyapatite implants.

Built / tested: coralline hydroxyapatite

As reported in: Holmes (1979). Bone Regeneration Within a Coralline Hydroxyapatite Implant. Plastic and Reconstructive Surgery. doi:10.1097/00006534-197905000-00004

Abstract only

commercial Medicines from animal venoms 1977

Designing the first ACE inhibitors

Ondetti, Rubin and Cushman used a model of the angiotensin-converting enzyme's active site to design a new class of orally active inhibitors that lowered blood pressure in rats, the work behind captopril.

Built / tested: captopril

As reported in: Ondetti, Rubin, Cushman (1977). Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents. Science. doi:10.1126/science.191908

Abstract only

lab Platinum (cancer drugs and catalysis) 1969

Platinum anticancer compounds

Rosenberg and colleagues reported platinum compounds as potent antitumor agents, leading to cisplatin.

As reported in: ROSENBERG, VANCAMP, TROSKO et al. (1969). Platinum Compounds: a New Class of Potent Antitumour Agents. Nature. doi:10.1038/222385a0

Abstract only

lab Liposomes and lipid nanoparticles 1965

First liposomes

Bangham and colleagues described swollen phospholipid layers, the first liposomes.

As reported in: Bangham, Standish, Watkins (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of Molecular Biology. doi:10.1016/S0022-2836(65)80093-6

Abstract only

lab Medicines from animal venoms 1965

Pit viper venom boosts bradykinin

Ferreira found that the venom of the Brazilian pit viper Bothrops jararaca contains a factor that strongly potentiates the action of bradykinin, and studied its chemical nature.

As reported in: FERREIRA (1965). A BRADYKININ‐POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARACA. British Journal of Pharmacology and Chemotherapy. doi:10.1111/j.1476-5381.1965.tb02091.x

Read free · publisher open access

lab Platinum (cancer drugs and catalysis) 1965

Accidental discovery of platinum effects

Rosenberg and colleagues found that products from platinum electrodes stopped bacteria from dividing.

As reported in: ROSENBERG, VAN CAMP, KRIGAS (1965). Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode. Nature. doi:10.1038/205698a0

Abstract only

commercial Hydrogels 1960

Hydrophilic gels

Wichterle and Lím introduced hydrophilic gels for biological use, leading to soft contact lenses.

Built / tested: soft contact lenses

As reported in: WICHTERLE, LÍM (1960). Hydrophilic Gels for Biological Use. Nature. doi:10.1038/185117a0

Abstract only

lab Xenon 1951

Xenon as an anaesthetic

Cullen and Gross described the anaesthetic properties of xenon in animals and human beings, with additional observations on krypton.

As reported in: Cullen, Gross (1951). The Anesthetic Properties of Xenon in Animals and Human Beings, with Additional Observations on Krypton. Science. doi:10.1126/science.113.2942.580

Abstract only

prototype Lithium 1949

Lithium salts for psychotic excitement

Cade reported on using lithium salts to treat psychotic excitement.

As reported in: Cade (1949). LITHIUM SALTS IN THE TREATMENT OF PSYCHOTIC EXCITEMENT. Medical Journal of Australia. doi:10.5694/j.1326-5377.1949.tb36912.x

Abstract only

lab Proton and particle beam therapy 1946

Proposing fast protons for therapy

Wilson proposed the radiological use of fast protons from higher-energy accelerators.

As reported in: Wilson (1946). Radiological Use of Fast Protons. Radiology. doi:10.1148/47.5.487

Abstract only

prototype Iodine 1946

Radioactive iodine for hyperthyroidism

Hertz reported a three-to-five-year follow-up of 29 patients with hyperthyroidism treated from 1941 to 1946 with "internal irradiation" from radioactive iodine.

As reported in: HERTZ (1946). RADIOACTIVE IODINE IN THE STUDY OF THYROID PHYSIOLOGY. Journal of the American Medical Association. doi:10.1001/jama.1946.02870190005002

Abstract only

lab Classic mathematical models of life (Lotka–Volterra, SIR, Hodgkin–Huxley) 1927

Mathematical theory of epidemics

Kermack and McKendrick developed a mathematical theory of epidemic spread, the origin of SIR models.

As reported in: Kermack, McKendrick (1927). A contribution to the mathematical theory of epidemics. Proceedings of the Royal Society of London. Series A, Containing Papers of a Mathematical and Physical Character. doi:10.1098/rspa.1927.0118

Read free · publisher open access